|
2024
|
Invention
|
Methods of treating hemophilia a.
The present disclosure provides a method of treating hemophili... |
|
|
Invention
|
Formulations of factor viii chimeric proteins and uses thereof.
The present disclosure provides ... |
|
|
Invention
|
Nucleic acids encoding factor viii polypeptides with reduced immunogenicity.
The present disclos... |
|
|
Invention
|
Engineered itr sequences and methods of use.
The present disclosure provides nucleic acid molecu... |
|
|
Invention
|
Baculovirus expression system.
Provided herein is a baculovirus expression vector system for the... |
|
|
Invention
|
Methods for treating hemophilia a and estimating bleed risk and uses thereof. The present disclos... |
|
2023
|
Invention
|
Population pharmacokinetics tools and uses thereof.
The present invention is directed to compute... |
|
|
Invention
|
Optimized factor viii gene.
The present invention provides codon optimized Factor VIII sequences... |
|
|
Invention
|
Optimized factor viii genes.
The present disclosure provides codon optimized Factor VIII sequenc... |
|
|
Invention
|
Methods for treating hemophilia a and population pharmacokinetics tools for determining treatment... |
|
|
Invention
|
Thrombin cleavable linker with xten and its uses thereof.
The present invention provides a chime... |
|
|
Invention
|
Oxindole derivatives as ampk activators for use in the treatment of rare blood disorders. This di... |
|
|
Invention
|
Ampk activators and methods of use thereof.
This disclosure to methods for treating or preventin... |
|
|
P/S
|
Pharmaceutical products for the prevention and treatment of blood disorders; pharmaceutical produ... |
|
|
Invention
|
Factor ix polypeptide formulations.
The present invention provides formulations comprising a Fac... |
|
|
Invention
|
Methods of treating hemophilia a. The present disclosure provides a method of treating hemophilia... |
|
|
Invention
|
On-column viral inactivation methods. The present invention is directed to a method of inactivati... |
|
2022
|
Invention
|
Recombinant factor viii proteins.
Provided are recombinant Factor VIII proteins, e.g., human Fac... |
|
|
Invention
|
Factor viii compositions and methods of making and using same.
The present invention relates to ... |
|
|
Invention
|
Formulations of factor viii chimeric proteins and uses thereof. The present disclosure provides p... |
|
|
Invention
|
Nucleic acids encoding factor viii polypeptides with reduced immunogenicity. The present disclosu... |
|
|
Invention
|
Closed-end dna production with inverted terminal repeat sequences.
The present disclosure provid... |
|
|
Invention
|
Optimized factor viii genes. The present disclosure provides codon optimized Factor VIII sequence... |
|
|
Invention
|
Closed-end dna production with inverted terminal repeat sequences. The present disclosure provide... |
|
|
Invention
|
Baculovirus expression system. Provided herein is a baculovirus expression vector system for the ... |
|
|
Invention
|
Baculovirus expression system. ParvoviridaeParvoviridae. |
|
|
Invention
|
Engineered itr sequences and methods of use. The present disclosure provides nucleic acid molecul... |
|
|
Invention
|
Device container.
Device containers, such as therapeutic kit containers, are disclosed. In one e... |
|
|
Invention
|
Immunoglobulin chimeric monomer-dimer hybrids.
The invention relates to a chimeric monomer-dimer... |
|
|
Invention
|
Chimeric factor viii polypeptides and uses thereof.
The present invention provides a VWF fragmen... |
|
|
Invention
|
Blood factor monitoring assay and uses thereof.
The present disclosure provides methods and comp... |
|
|
Invention
|
Methods of reducing immunogenicity against factor viii in individuals undergoing factor viii ther... |
|
|
Invention
|
Factor viii-fc chimeric and hybrid polypeptides, and methods of use thereof.
The present inventi... |
|
|
Invention
|
Procoagulant compounds.
The present disclosure provides protease-activatable procoagulant compou... |
|
2021
|
Invention
|
Factor viii chimeric proteins and uses thereof.
The present invention provides a chimeric protei... |
|
|
Invention
|
Chimeric clotting factors.
The invention provides chimeric clotting factors comprising an activa... |
|
|
Invention
|
Ampk activators and methods of use thereof. This disclosure to methods for treating or preventing... |
|
|
P/S
|
Providing product and treatment information to patients and healthcare professionals in the field... |
|
|
P/S
|
Pharmaceutical preparations for the treatment of blood disorders; pharmaceutical preparations for... |
|
2020
|
Invention
|
Recombinant factor viii-fc for treating hemophilia and low bone mineral density.
Disclosed herei... |
|
2019
|
P/S
|
Pharmaceutical products for treating cold agglutinin disease |
|
|
P/S
|
Pharmaceutical products to treat cold agglutinin disease. |
|
|
P/S
|
Pharmaceutical preparation for the treatment of cold agglutinin disease |
|
|
P/S
|
Pharmaceutical product to treat cold agglutinin disease. |
|
|
P/S
|
Pharmaceutical preparations for the treatment of cold agglutinin disease and chronic immune throm... |
|
|
P/S
|
Pharmaceutical preparation for the treatment of cold agglutinin disease |
|
2017
|
Invention
|
Bispecific antibodies binding to coagulation factor ix and coagulation factor x.
The present dis... |
|
|
P/S
|
Computer software for controlling and managing patient medical information |
|
|
P/S
|
Pharmaceutical drug development services. |
|
|
P/S
|
Pharmaceutical drug development services |
|
2014
|
P/S
|
Providing product and treatment information to patients in the field of hemophilia |
|
|
P/S
|
Providing medical information in the field of hemophilia |
|
2011
|
P/S
|
Pharmaceutical preparations for the treatment of hemophilia. |
|
|
P/S
|
Pharmaceutical preparations for the treatment of hemophilia |
